Literature DB >> 2647560

Initial pathogenic events in IDDM.

N Maclaren1, D Schatz, A Drash, G Grave.   

Abstract

A workshop sponsored by the National Institute of Child Health and Human Development was held in June 1988 to discuss the initial events in the pathogenesis of insulin-dependent diabetes and to make recommendations for future studies. Better definition of immunological markers to reliably predict the disease will enable the detection and study of the earliest pathogenic events involved. The precise autoimmune mechanisms and the role of the environment, both in the initiation of the disease process and precipitation of clinically overt disease, need to be accurately determined to define strategies that might eventually lead to its prevention.

Entities:  

Mesh:

Year:  1989        PMID: 2647560     DOI: 10.2337/diab.38.4.534

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Raised temperature reduces the incidence of diabetes in the NOD mouse.

Authors:  A J Williams; J Krug; E F Lampeter; K Mansfield; P E Beales; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

3.  Lack of agreement among two commercial enzyme-linked immunosorbent antibody assays and a conventional immunofluorescence-based method for detecting islet cell autoantibodies.

Authors:  E J Baron; D E Weber; L G Weide
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.

Authors:  D Schatz; J Krischer; G Horne; W Riley; R Spillar; J Silverstein; W Winter; A Muir; D Derovanesian; S Shah
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

Authors:  D M See; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

6.  Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).

Authors:  J S Petersen; M O Marshall; S Baekkeskov; K R Hejnaes; M Høier-Madsen; T Dyrberg
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

7.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

8.  The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions.

Authors:  Cecile King; Nora Sarvetnick
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.